Long Term Follow-up for RGX-202

Enrolling by invitationOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

May 8, 2024

Primary Completion Date

December 1, 2029

Study Completion Date

December 1, 2029

Conditions

Duchenne Muscular Dystrophy

Interventions

GENETIC

No Intervention

Observational study

Trial Locations (2)

Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago

Arkansas Children's Hospital, Little Rock

All Listed Sponsors

lead

REGENXBIO Inc.

INDUSTRY